why choose us

First received: February 22, 2025

Clinical Trial: Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Recurrent Urinary Tract Infection

Study Type: INTERVENTIONAL


Official Title: Interventional Study on the Efficacy of Lactobacillus Crispatus M247 for Prevention and Treatment of Recurrent Urinary Tract Infections in Combination With Enterococcus Faecium L3 and Bifidobacterium

Brief Summary: This randomized, open-label, controlled clinical trial evaluates the efficacy and safety of Lactobacillus crispatus M247 (CRISPACT®) in preventing recurrent urinary tract infections (rUTIs) in women.The study enrolls 84 adult female participants with a history of recurrent UTIs, defined as ?3 episodes in the past year or ?2 episodes in the past six months.Participants are randomized into two groups: the Probiotic Group, receiving iNatal Duo® (containing Bifidobacterium animalis subsp.lactis BB-12 and Enterococcus…

Read more